M1559

Moxonidine hydrochloride

Name: Moxonidine hydrochloride
Brand: SIGMA
Price: 114.75 USD

≥98%

Synonym(s):

4-Chloro-6-methoxy-2-methyl-5-(2-imidazolin-2-yl)aminopyrimidine hydrochloride, BDF-5895

Slide 1 of 2

Select a Size

10 MG

$114.75

25 MG

$226.95

$114.75

List Price$135.00Save 15%

Check Cart for Availability

One Time Order

Request a Bulk Order

Subscriptions are currently unavailable.

About This Item

Empirical Formula (Hill Notation):

C₉H₁₂ClN₅O · HCl

CAS Number:

75438-58-3

Molecular Weight:

278.14

MDL number:

MFCD06795643

UNSPSC Code:

12352200

PubChem Substance ID:

24278537

NACRES:

NA.77

Key Documents

View All Documentation

assay

≥98%

originator

Solvay

SMILES string

Cl.COc1nc(C)nc(Cl)c1NC2=NCCN2

InChI

1S/C9H12ClN5O.ClH/c1-5-13-7(10)6(8(14-5)16-2)15-9-11-3-4-12-9;/h3-4H2,1-2H3,(H2,11,12,15);1H

InChI key

ZZPAWQYZQVUVHX-UHFFFAOYSA-N

Gene Information

human ... ADRA2A(150), ADRA2B(151), ADRA2C(152), NISCH(11188)

Related Categories

Bioactive Small Molecule Agonists

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	E3263	T6950	R9525
Sigma-Aldrich M1559 Moxonidine hydrochloride	Sigma-Aldrich E3263 Efaroxan hydrochloride	Sigma-Aldrich T6950 Tizanidine hydrochloride	Sigma-Aldrich R9525 RX 821002 hydrochloride
assay ≥98%	assay ≥98% (HPLC)	assay ≥98% (HPLC)	assay ≥98% (HPLC)
Quality Level 100	Quality Level 100	Quality Level 100	Quality Level 100
originator Solvay	originator -	originator Acorda Therapeutics	originator -
Gene Information human ... ADRA2A(150), ADRA2B(151), ADRA2C(152), NISCH(11188)	Gene Information human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152)	Gene Information human ... ADRA2A(150), ADRA2B(151), ADRA2C(152)	Gene Information human ... ADRA2A(150), ADRA2B(151), ADRA2C(152)

Application

Moxonidine hydrochloride has been used:

as a standard to study its blood-brain barrier (BBB) permeability in porcine brain lipid extract by parallel artificial membrane permeability assay (PAMPA) method[1]
as a standard to study the chromatographic behavior and lipophilicity by reversed-phase thin-layer chromatography (RP-TLC)[2]
as an imidazoline I1 receptor agonist to study its effects on excitatory inputs in airway vagal preganglionic neuron (AVPN)[3]

Biochem/physiol Actions

Moxonidine is a selective high-affinity imidazoline I1-receptor agonist and a selectively low-affinity α2-adrenoceptor agonist. It exhibits anti-hypertensive properties by reducing blood pressure efficiently.[4] Moxonidine also exhibits spinal analgesic activity through the α_2C-adrenoceptor component.[5]

Features and Benefits

This compound is featured on the Imidazoline Binding Sites page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Solvay. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

020K4700

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Moxonidine inhibits excitatory inputs to airway vagal preganglionic neurons via activation of both α2-adrenoceptors and imidazoline I1 receptors.

Xujiao Zhou et al.

Brain research, 1732, 146695-146695 (2020-02-03)

As an imidazoline I1 receptor agonist with very weak binding affinity for α2-adrenoceptors, moxonidine is commonly used in the treatment of hypertension. Moxonidine also has been implicated to act centrally to reduce airway vagal outflow. However, it is unknown at

Estimation of lipophilicity and retention behavior of some alpha adrenergic and imidazoline receptor ligands using RP-TLC

Mohamed S, et al.

Journal of Liquid Chromatography and Related Technologies, 37(20), 2829-2845 (2014)

Site of action of moxonidine in the rat nephron.

J Greven et al.

Naunyn-Schmiedeberg's archives of pharmacology, 364(6), 496-500 (2002-01-05)

Moxonidine is a centrally acting antihypertensive agent which has been found to exert its blood pressure lowering effect by interaction with (alpha2-adrenoceptors and imidazoline receptors of the I(1)-type. These receptors have also been demonstrated to be present in the rat

The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones.

C Bing et al.

British journal of pharmacology, 127(1), 35-42 (1999-06-16)

The antihypertensive agent moxonidine, an imidazoline Ii-receptor agonist, also induces hypophagia and lowers body weight in the obese spontaneously hypertensive rat, but the central mediation of this action and the neuronal pathways that moxonidine may interact with are not known.

Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.

Jelica Vucicevic et al.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 68, 94-105 (2014-12-30)

Imidazoline receptor ligands are a numerous family of biologically active compounds known to produce central hypotensive effect by interaction with both α2-adrenoreceptors (α2-AR) and imidazoline receptors (IRs). Recent hypotheses connect those ligands with several neurological disorders. Therefore some IRs ligands

View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Moxonidine hydrochloride